BCBS gives Cologuard positive review: 3 key notes

Blue Cross Blue Shield Association’s Center for Clinical Effectiveness positively reviewed Madison, Wis.-based Exact Sciences’ Cologuard, a fecal-based colonoscopy alternative.

Advertisement

Here’s what you need to know.

1. The association represents 36 Blue Cross and Blue Shield companies.

2. Approximately two thirds of all BCBS companies cover Cologuard.

3. Exact Sciences CEO Kevin Conroy said the review “affirms that Cologuard has a positive impact on health outcomes and provides additional support for the remaining plans to offer their members our patient-friendly non-invasive colon cancer screening option.”

More articles on gastroenterology/endoscopy:
Dr. J. Calvin Coffey urges classification new abdominal organ: 5 things to know
GI leader to know: Dr. Joseph Binns of Red Bank Gastroenterology
Methodist Dallas Medical Center pancreatitis program earns rare Joint Commission seal: 3 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.